NEWRON PHARMACEUTICALS S.P.A. EUR0.20 financial statements, including revenue, expenses, and profit
The total revenue of 0QOI for the last semiannual is 45.29 M CHF, and it's 1282.34% higher compared to the previous semiannual. The net income of H2 24 is 23.97 M CHF.